Skip to main content
. 2020 Nov 19;11:483570. doi: 10.3389/fneur.2020.483570

Figure 2.

Figure 2

(A) Forest plot of estimated relative risk of stroke recurrence in trials of lipid-lowering treatment (5 trials with 1,821 ischemic stroke patients). (B) Standardized associations between LDL-C reduction and relative risk of stroke recurrence (5 trials with 371 ischemic stroke patients who experienced LDL-C reduction by 30–50%).